MedTrace Logo

Monitoring Blood Flow and Breathing Using a New Device (RFII) Compared to the Gold Standard Device in Post Operative Cardiac Patients

NCT01434771 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2013-10-16

No results posted yet for this study

Summary

The purpose of this study will be to compare standard of care invasive methods to an FDA approved non-invasive device and a novel wireless non-invasive device, both manufactured by Non-Invasive Medical Technologies Inc., with the goal of correlating the data generated by the novel device to the measurements taken by the standard of care invasive monitors.

Conditions

  • Noninvasive Cardiac Monitoring

Sponsors & Collaborators

  • Noninvasive Medical Technologies, Inc.

    collaborator INDUSTRY

  • United States Department of Defense

    collaborator FED

  • University of Florida

    lead OTHER

Principal Investigators

  • Kevin L Ferguson, MD · University of Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01434771 on ClinicalTrials.gov